Find comprehensive information on Transcatheter Aortic Valve Replacement TAVR including clinical documentation requirements medical coding guidelines and healthcare best practices. Learn about TAVR procedure codes ICD-10 codes for aortic stenosis postoperative care and quality reporting measures. This resource provides essential information for physicians coders and healthcare professionals involved in TAVR diagnosis treatment and documentation. Explore TAVR complications valve types and patient selection criteria. Improve your understanding of TAVR clinical pathways and optimize your documentation for accurate reimbursement.
Also known as
Insertion of aortic valve prosthesis
Placement of aortic valve replacement via catheter.
Replacement of aortic valve
Exchange of diseased aortic valve with prosthesis.
Aortic stenosis
Narrowing of the aortic valve opening.
Nonrheumatic aortic valve disorders
Aortic valve problems not caused by rheumatic fever.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is TAVR being performed?
Yes
Is it for native aortic valve?
No
Do not code TAVR. Review clinical documentation for correct diagnosis.
When to use each related code
| Description |
|---|
| Transcatheter Aortic Valve Replacement |
| Surgical Aortic Valve Replacement |
| Aortic Valve Stenosis |
Incomplete documentation of the specific TAVR device used can lead to inaccurate coding and claims.
Incorrect coding for valve-in-valve procedures during TAVR can result in underpayment or denials.
Failure to capture and code all TAVR-related complications affects accurate DRG assignment and reimbursement.
Q: What are the latest evidence-based guidelines for patient selection in transcatheter aortic valve replacement (TAVR) for severe aortic stenosis?
A: Patient selection for TAVR is crucial for optimizing outcomes. Current guidelines, such as those from the American College of Cardiology (ACC) and American Heart Association (AHA), prioritize a multidisciplinary heart team approach to assess surgical risk using validated tools like the STS score. These guidelines emphasize considering TAVR in patients with severe symptomatic aortic stenosis who are at intermediate or high surgical risk, or those deemed inoperable. Furthermore, factors like frailty, comorbidities, and anatomical suitability are now increasingly incorporated into the decision-making process. Explore how shared decision-making can further enhance patient-centered TAVR care by considering individual patient preferences and values alongside clinical guidelines.
Q: How can I effectively manage and mitigate the risk of post-TAVR complications, including paravalvular leak, conduction abnormalities, and stroke, in my clinical practice?
A: Post-TAVR complications require careful management. Paravalvular leak can be minimized with meticulous procedural technique and appropriate valve sizing, aided by advanced imaging modalities. Conduction abnormalities may necessitate permanent pacemaker implantation; therefore, pre-procedural electrocardiographic assessment and close post-procedure monitoring are essential. Stroke risk can be mitigated by employing cerebral protection devices and optimizing antithrombotic therapy post-TAVR. Consider implementing a standardized post-TAVR surveillance protocol encompassing echocardiography, electrocardiography, and neurological assessment to facilitate early detection and prompt intervention for any emerging complications.
Patient presents for evaluation of symptomatic severe aortic stenosis. Symptoms include dyspnea on exertion, angina, and syncope, consistent with New York Heart Association functional class III. Transthoracic echocardiogram confirms severe aortic stenosis with a mean gradient of [insert value] mmHg and aortic valve area of [insert value] cm2. Patient deemed high-risk surgical candidate for traditional aortic valve replacement due to [list specific comorbidities, e.g., advanced age, severe COPD, prior cardiac surgery]. After multidisciplinary heart team discussion, including cardiology and cardiothoracic surgery, the patient is determined to be a suitable candidate for transcatheter aortic valve replacement (TAVR). Risks and benefits of TAVR versus open surgical aortic valve replacement (SAVR) were thoroughly discussed with the patient, including procedural complications such as stroke, vascular injury, paravalvular leak, and bleeding. Informed consent obtained. Pre-procedural workup includes coronary angiography, computed tomography aortography, and transesophageal echocardiography to assess coronary anatomy, aortic annulus dimensions, and feasibility of transcatheter access. Planned TAVR approach is [specify transfemoral, transapical, transaortic, or trans-subclavian]. Anticipated valve size is [insert size] based on imaging. Patient scheduled for TAVR procedure. Diagnosis: Severe aortic stenosis. Procedure: Transcatheter aortic valve implantation (TAVI). ICD-10 code: I35.0 (Aortic valve stenosis). CPT codes will be determined based on the specific procedural approach and adjunctive procedures performed.